Translations:Riboflavin/2/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
(No difference)

Latest revision as of 16:27, 19 February 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Riboflavin)
<!-- Clinical data -->
| pronounce        = 
| tradename        = Many
| Drugs.com        = {{Drugs.com|monograph|Riboflavin}}
| MedlinePlus      = 
| licence_EU        = <!-- EMA requires brand name -->
| DailyMedID        = Riboflavin
| licence_US        = <!-- FDA may use generic name -->
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_AU_comment =     
| pregnancy_US      = A
| pregnancy_US_comment = and C
| pregnancy_category= 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = [[Oral administration|By mouth]], [[intramuscular]], [[intravenous]]
| class            = 
| ATCvet            = 
| ATC_prefix        = A11
| ATC_suffix        = HA04
| ATC_supplemental  = {{ATC|S01|XA26}}

| pronounce = | tradename = Many | Drugs.com = Monograph | MedlinePlus = | licence_EU = | DailyMedID = Riboflavin | licence_US = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_US = A | pregnancy_US_comment = and C | pregnancy_category= | dependency_liability = | addiction_liability = | routes_of_administration = By mouth, intramuscular, intravenous | class = | ATCvet = | ATC_prefix = A11 | ATC_suffix = HA04 | ATC_supplemental = S01XA26 (WHO)